• About
  • The Company
  • Management Team
  • Scientific Advisory Board
  • Board of Directors
  • Investors
• Science & Biology
  • Diabetes
  • Insulin Resistance
  • Obesity
• Programs
  • INT131
• News & Media
  • Press Releases
  • Media Contact

• Press Releases
• Media Contact

News and Media

August 4, 2008:
InteKrin Therapeutics Announces $20 Million Series C Financing

June 8, 2008:
InteKrin Therapeutics Presents Phase 2a Data at American Diabetes Association 68th Scientific Sessions held in San Francisco, California for INT131, a non-TZD SPPARM. Download Poster